LGYV
Industry:
Pharma & Biotech

DESCRIPTION

Legacy Ventures International is a shell company with no operations, no revenue, and no products or customers. Its only activity is incurring general and administrative expenses, primarily professional fees for SEC compliance. These costs are funded entirely by interest-free loans from its majority shareholder and a director. In December 2023, Legacy Ventures incorporated a wholly owned Hong Kong subsidiary, Ever Green Living Ventures, through which the company plans to pursue biotech and healthcare R&D. However, this subsidiary has no operations, and no funding, personnel, partnerships, or research activities have been disclosed.

Read full business overview →